Search Results 401-410 of 14773 for anti-TNF drugs

1. Treatment of Achilles tendinopathy - Mayo Clinic

   ... therapy in the insertional group. There is mixed evidence for prolotherapy and use of nonsteroidal anti-inflammatory drugs (NSAIDs) in both groups.

2. RA-PRO PRAGMATIC TRIAL - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... TNF-biologic. Participation eligibility ... Latent TB not treated with anti-mycobacterial medication.

3. Mayo Clinic Comprehensive Cancer Center Research

   Research in the Experimental Therapeutics Program of Mayo Clinic Comprehensive Cancer Center focuses on signaling pathways, anti-cancer drugs, ...

4. Amiodarone (Intravenous Route) Before Using - Mayo Clinic

   An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

5. Cognitive behavioral therapy - Mayo Clinic

   Cognitive behavioral therapy (CBT) is a common type of talk therapy (psychotherapy). You work with a mental health counselor (psychotherapist or therapist) in a ...

6. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

   ... [anti-TNF] agents) within 14 days prior to randomization. Exceptions ... agents, corticosteroids or immunosuppressive drugs). Replacement therapy (e.g. ...

7. Ingrown toenails - Diagnosis & treatment - Mayo Clinic

   Learn about causes, prevention and treatment of this common, painful nail condition that usually affects the big toe.

8. CAR-T Cell Therapy Program - Department home - Mayo Clinic

   Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...

9. A Study of Atrial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke - Mayo Clinic

   The primary purpose of this study is to test the theory that Eliquis (apixaban) is superior to aspirin for the prevention of recurrent stroke in patients with ...

10. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Subject who received nonsteroidal anti-inflammatory drugs (NSAIDs) within 7 days prior to Baseline, except topical NSAIDs and low dose aspirin for ...